top of page

Promising Results In Stopping Tumors. A Brno University Startup Raises 40 Million

Translated by Milo Dvorak

1. 2. 2024

Business Newsletter #4

Good morning,

Here is your next Business Newsletter. This time, I've included two articles.

1) The Czech Republic can boast about having brilliant minds in every conceiveable field. But I think it's safe to say that medicine is, historically speaking at least, at the top.

2) (Note: separate article on the web.) If you've ever used the Czech Post services at the Jindrisska building, you'll have noticed the majesty and spatial generousity the interior offers. And you may also have noticed just how inefficient the service unfortunately is, hence why the Czech Post has been trying to slash their operational costs.

Happy reading!

Published by CzechCrunch on 31 January 2024.

CasInvent Pharma develops drugs for patients suffering from very serious diseases, such as leukemia or certain types of breast cancer.CasInvent Pharma was created as a spin-off four years ago through the collaboration of Masaryk University and the bio-innovation centre i&i Prague. It specialises in the development of highly selective enzyme inhibitors that play a crucial role in processes related to the onset of severe diseases. Inhibitors, which generally slow down or completely prevent a specific chemical reaction, in the case of CasInvent, eliminate leukemic cells, but there is also potential for other diseases. The company has received support from investors for the second time in its development.

Read the full article here.

bottom of page